410 results on '"Pritchard, D. Mark"'
Search Results
2. Sequence of Contact X-ray Brachytherapy (CXB) and External Beam Radiation (EBRT) in organ-preserving treatment for small rectal cancer
3. Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter
4. Contact x-ray brachytherapy for the treatment of rectal cancer: A systematic review and meta-analysis.
5. Clinical prediction models assessing response to radiotherapy for rectal cancer: protocol for a systematic review
6. New Developments in Gastric Neuroendocrine Neoplasms
7. Neuroendocrine neoplasms: Consensus on a patient care pathway
8. Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?
9. Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors
10. Nonlinear machine learning pattern recognition and bacteria-metabolite multilayer network analysis of perturbed gastric microbiome
11. A Budget Impact Model of the Addition of Telotristat Ethyl Treatment to the Standard of Care in Patients with Uncontrolled Carcinoid Syndrome
12. A dynamic model of the intestinal epithelium integrates multiple sources of preclinical data and enables clinical translation of drug‐induced toxicity
13. Dose Escalation Using Contact X-ray Brachytherapy After External Beam Radiotherapy as Nonsurgical Treatment Option for Rectal Cancer: Outcomes From a Single-Center Experience
14. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3
15. Risk factors and clinical correlates of neoplastic transformation in gastric hyperplastic polyps in Chinese patients
16. Potential clinical indications for a CCK2 receptor antagonist
17. Multiple and diverse consequences of inhibiting gastric acid secretion: remembering the bicentenary of William Prout’s discovery
18. Data from IFN-γ Inhibits Gastric Carcinogenesis by Inducing Epithelial Cell Autophagy and T-Cell Apoptosis
19. Supplementary Figure Legends 1-7 from IFN-γ Inhibits Gastric Carcinogenesis by Inducing Epithelial Cell Autophagy and T-Cell Apoptosis
20. Supplementary Table 1 from IFN-γ Inhibits Gastric Carcinogenesis by Inducing Epithelial Cell Autophagy and T-Cell Apoptosis
21. Supplementary Figures 1-7 from IFN-γ Inhibits Gastric Carcinogenesis by Inducing Epithelial Cell Autophagy and T-Cell Apoptosis
22. Inhibition by Uridine but not Thymidine of p53-Dependent Intestinal Apoptosis Initiated by 5-fluorouracil: Evidence for the Involvement of RNA Perturbation
23. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3.
24. NF-κB2 signalling in enteroids modulates enterocyte responses to secreted factors from bone marrow-derived dendritic cells
25. Homeostasis, injury and recovery dynamics at multiple scales in a self-organizing intestinal crypt
26. OGC O08 Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10mm in diameter
27. Letter to the editor:Helicobacter pylorieradication – the proof is not in the symptoms
28. Nfkb2 deficiency and its impact on plasma cells and immunoglobulin expression in murine small intestinal mucosa
29. New hope from OPERA trial for surgically fit rectal cancer patients who wish to have organ preservation
30. Netazepide, a gastrin/cholecystokinin‐2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis
31. Genetic Determinants of Cell Death and Toxicity
32. Role of Bcl-2 Family Members in Homeostasis, in Toxicology in Normal Intestine, and for Prognosis of Colonic Carcinomas
33. Additional file 1 of Clinical prediction models assessing response to radiotherapy for rectal cancer: protocol for a systematic review
34. Additional file 2 of Clinical prediction models assessing response to radiotherapy for rectal cancer: protocol for a systematic review
35. Multiple and diverse consequences of inhibiting gastric acid secretion: remembering the bicentenary of William Prout's discovery.
36. New Mouse Model Suggests That Some Neuroendocrine Tumors May Originate From Neural Crest–Derived Cells
37. Genome-Wide association between EYA1 and Aspirin-induced peptic ulceration
38. Conditional Deletion of IκB-Kinase-β Accelerates Helicobacter-Dependent Gastric Apoptosis, Proliferation, and Preneoplasia
39. Effects of Proton Pump Inhibitor Therapy, H. pylori Infection and Gastric Preneoplastic Pathology on Fasting Serum Gastrin Concentrations
40. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults
41. NF-κB1, NF-κB2 and c-Rel differentially regulate susceptibility to colitis-associated adenoma development in C57BL/6 mice
42. Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour
43. Gastrin Receptor Pharmacology
44. Myths and misconceptions in the management of Helicobacter pylori infection
45. Cost-effectiveness modelling of use of urea breath test for the management of Helicobacter pylori-related dyspepsia and peptic ulcer in the UK
46. Oral Ferric Maltol Does Not Adversely Affect the Intestinal Microbiome of Patients or Mice, but Ferrous Sulphate Does
47. The Impact of 68Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours
48. Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?
49. The management of gastric polyps
50. KLF4 gene expression is inhibited by the notch signaling pathway that controls goblet cell differentiation in mouse gastrointestinal tract
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.